Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
Sernova’s CEO on how the Cell Pouch System tackles diabetes
Advancing cell therapeutics to provide 'functional cures'
News Alert: Sernova - Developing a Functional Cure for Type I Diabetes
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
Dr Philip Toleikis, Sernova, Cell Pouch technology, islet cell transplants, glucose responsive techn
Sernova Corp
Sernova Cell Pouch Hopes to Improve Islet Transplant Success | Insulin Nation
Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram
SERNOVA CORP.
Sernova touts data on cell pouch for treating insulin-dependent diabetes
Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech
Sernova and Evotec collaborate to develop cell therapy for diabetes
Is Sernova’s Cell Pouch System a Functional Cure for T1D? An update from CEO Cynthia Pussinen
Sernova | Dr. Piotr Witkowski | UChicago
Type 1 diabetes goes on trial – Eric Bender
Sernova Receives FDA IND Allowance To Initiate A U.S. Clinical Trial Of Its Cell Pouch | Medical Product Outsourcing
Sernova and AstraZeneca to study therapeutic cell applications
Sernova and Evotec on Track to Initiate Clinical Testing of First iPSC-Derived Islets as a Potential Functional Cure for Type 1 Diabetes | BioInformant
🔬 Sernova's conformal coating technology improves immune protection and biocompatibility. | Cynthia Pussinen posted on the topic | LinkedIn
Sernova on X: "#ICYMI, an update from our Phase 1/2 study of our Cell Pouch with islet transplantation, our candidate in development for a potential 'functional cure' of insulin-dependent diabetes, was presented
Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare
Sernova Corp
Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram
Sernova - News
